1284
W. Su et al.
LETTER
(12) Ismail, M. M.; Abass, M.; Hassan, M. M. Molecules 2000, 5,
1224.
Supporting Information for this article is available online at
(13) Experimental Procedure for the Synthesis of 4-Chloro-2-
substituted Quinolines; 1,3-(2H)-dicarbaldehyde 1o–r:
To an ice-cold magnetically stirred solution of DMF (10 mL)
and 2-arylquinoline (5.0 mmol), POCl3 (30 mmol, 2.8 mL)
was added dropwise. The reaction mixture was heated to
50 °C for 3 h. After which it was poured into the crush ice,
neutralized with sat. K2CO3 solution and extracted with
EtOAc. After drying and condensation of the organic layer ,
the crude reaction product was purified by column
chromatography using 5% EtOAc in PE as eluent to afford
pure 1o–r.
Acknowledgment
We are grateful to the National Key Technology R&D Program
[2007BAI34B00], the National Natural Science Foundation of Chi-
na [No. 20876147] and the Opening Foundation of Zhejing Provin-
cial Top Key Pharmaceutical Discipline for financial support.
References and Notes
(14) (a) Brahma, S.; Ray, J. K. J. Heterocycl. Chem. 2008, 45,
311. (b) Brahma, S.; Ray, J. K. Tetrahedron Lett. 2005, 46,
6575. (c) Becher, J.; Jorgensen, P. L.; Pluta, K.; Krake, N. J.;
Falt-Hansen, B. J. Org. Chem. 1991, 57, 2127.
(1) (a) Kleeman, A.; Engel, J.; Kutscher, B.; Reichert, D.
Pharmaceutical Substances, Synthesis, Patents,
Applications; Thieme: Stuttgart, New York, 2001.
(b) Michael, J. P. Nat. Prod. Rep. 2001, 18, 543.
(c) Funayama, S.; Murata, K.; Noshita, T. Heterocycles
2001, 54, 1139.
(15) General Procedure for the Synthesis of 2-Substituted
Quinolines 2a–n: To a solution of DMSO (5 mL) and 4-
chloro-N-formyl-1,2-dihydroquinolines 1a–n (1.0 mmol),
NaN3 (1 mmol, 0.065 g) was added at r.t. The solution was
then heated at the indicated temperature (90 °C or 120 °C or
150 °C) for the indicated time. After completion of the
reaction (monitored by TLC) the mixture was treated with
ice-water and extracted with EtOAc. The organic layer was
washed with H2O, and then with brine. After condensation of
the organic layer, the products 2a–n were obtained by
column chromatography (PE–EtOAc).
(2) Huang, L. J.; Hsieh, M. C.; Teng, C. M.; Lee, K. H.; Kuo,
S. C. Bioorg. Med. Chem. 1998, 6, 1657.
(3) Musser, J. H.; Chakraborty, U. R.; Sciortino, S.; Gordon, R.
J.; Khandwala, A.; Neiss, E. S.; Pruss, T. P.; Van Inwegen,
R.; Weinryb, I.; Coutts, S. M. J. Med. Chem. 1987, 30, 96.
(4) Gauthier, J. Y.; Jones, T.; Champion, E.; Charette, L.;
Dehaven, R.; Ford-Hutchinson, A. W.; Hoogsteen, K.; Lord,
A.; Masson, P.; Piechuta, H.; Pong, S. S.; Springer, J. P.;
Therien, M.; Zamboni, R.; Young, R. N. J. Med. Chem.
1990, 33, 2841.
2-(2-Chloro-6-fluorophenyl)quinoline (2f)
New compound. Yield: 99%; light yellow oil; Rf 0.53 (PE–
EtOAc, 5:1). 1H NMR (400 MHz, CDCl3): d = 8.27 (1 H, d,
J = 8.0 Hz), 8.20 (1 H, d, J = 8.4 Hz), 7.89 (1 H, d, J = 8.0
Hz), 7.74–7.79 (1 H, m), 7.60 (1 H, t, J = 8.0 Hz), 7.50 (1 H,
(5) For example: (a) Majumder, S.; Gipson, K. R.; Odom, A. L.
Org. Lett. 2009, 11, 4720. (b) Martinez, R.; Ramon, D. J.;
Yus, M. J. Org. Chem. 2008, 73, 9778. (c) Schramm, O. G.;
Oeser, T.; Kaiser, M.; Brun, R.; Müller, T. J. J. Synlett 2008,
359. (d) Zhang, Z. H.; Tan, J. J.; Wang, Z. Y. Org. Lett.
2008, 10, 173. (e) Horn, J.; Marsden, S. P.; Nelson, A.;
House, D.; Weingarten, G. G. Org. Lett. 2008, 10, 4117.
(f) Li, L.; Jones, W. D. J. Am. Chem. Soc. 2007, 129, 10707.
(g) Sandelier, M. J.; DeShong, P. Org. Lett. 2007, 9, 3209.
(6) Li, H.; Zheng, C.; Chen, R. E.; Su, W. K. Org. Prep. Proced.
Int. 2009, 41, 156.
(7) (a) Wolf, C.; Lerebours, R. J. Org. Chem. 2003, 68, 7077.
(b) Pierce, A. C.; ter Haar, E.; Binch, H. M.; Kay, D. P.;
Patel, S. R.; Li, P. J. Med. Chem. 2005, 48, 1278.
(c) Andersen, K. E.; Lundt, B. F.; Jorgensen, A. S.;
Braestrup, C. Eur. J. Med. Chem. 1996, 31, 417. (d) Holla,
B. S.; Mahalinga, M.; Karthikeyan, M. S.; Poojary, B.;
Akberali, P. M.; Kumari, N. S. Eur. J. Med. Chem. 2005, 40,
1173. (e) Zhong, B. Y.; Al-Awar, R. S.; Shih, C.; Grimes,
J. H. Jr.; Vieth, M.; Hamdouchi, C. Tetrahedron Lett. 2006,
47, 2161. (f) Lim, J.; Stock, N.; Pracitto, R.; Boueres, J. K.;
Munoz, B.; Chaudhary, A.; Santini, A. M.; Orr, K.;
Schaffhauser, H.; Bezverkov, R. E.; Aiyar, J.; Venkatraman,
S. Bioorg. Med. Chem. Lett. 2004, 14, 1913.
d, J = 8.0 Hz), 7.32–7.38 (2 H, m), 7.11–7.16 (1 H, m). 13
C
NMR (100 MHz, CDCl3): d = 160.7 (d, 1JC–F = 248.7 Hz),
152.5, 147.9, 136.4, 134.3, 130.2 (d, 3JC–F = 9.9 Hz), 129.8,
129.6, 127.6, 127.3, 127.1, 125.6 (d, 4JC–F = 3.1 Hz), 123.0,
114.6 (d, 2JC–F = 22.0 Hz). HRMS (ESI): m/z [M + H]+ calcd
for C15H10ClFN: 258.0408; found: 258.0477.
(16) General Procedure for the Synthesis of 4-Substituted
Isoxazolo[4,3-c]quinolines-5-(4H)-carbaldehyde 3o–r:
To a solution of DMSO (5 mL) and 4-chloro-2-substituted
quinolines-1,3 (2H)-dicarbaldehyde 1o–r (1.0 mmol), NaN3
(1.5 mmol, 0.098 g) was added at r.t. and the reaction
mixture was kept at this temperature for 0.5 h. After
completion of the reaction (monitored by TLC) the mixture
was treated with ice-water and extracted with EtOAc. The
organic layer was washed with H2O, and then with brine.
After condensation of the organic layer, the products 3o–r
were obtained by column chromatography (PE–EtOAc).
4-Phenylisoxazolo[4,3-c]quinoline-5-(4H)-carbaldehyde (3o)
New compound. Yield: 88%; white crystals; mp 176–178
°C; Rf 0.46 (PE–EtOAc, 3:1). IR (KBr): 3121, 3057, 2851,
1677, 1609, 1574, 1475 cm–1. 1H NMR (400 MHz, DMSO):
d = 9.21 (1 H, s), 8.86 (1 H, s), 7.94 (1 H, d, J = 8.0 Hz), 7.73
(1 H, d, J = 8.0 Hz), 7.54–7.59 (1 H, m), 7.37–7.41 (1 H, m),
7.22–7.30 (3 H, m), 7.16 (2 H, d, J = 8.0 Hz), 7.10 (1 H, s).
13C NMR (100 MHz, DMSO): d = 162.4, 156.0, 153.8,
138.8, 136.1, 132.2, 128.7, 127.8, 126.3, 126.1, 124.6,
121.2, 117.1, 114.7, 46.9. HRMS (EI): m/z [M+] calcd for
C17H12N2O2: 276.0899; found: 276.0899.
(8) Sashida, H.; Fujii, A.; Tsuchiya, T. Chem. Pharm. Bull.
1987, 35, 3182.
(9) Smith, K. M.; Miura, M.; Tabba, H. D. J. Org. Chem. 1983,
48, 4779.
(10) Kumar, K. H.; Peruma, P. T. J. Heterocycl. Chem. 2008, 45,
597.
(11) Delfourne, E.; Darro, F.; Bontemps-Subielos, N.;
Decaestecker, C.; Bastide, J.; Frydman, A.; Kiss, R. J. Med.
Chem. 2001, 44, 3275.
Synlett 2010, No. 8, 1281–1284 © Thieme Stuttgart · New York